PHARMA AND CCS CONSULTING

Chaudfontaine ·KBO/BCE: BE 0772.858.683

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	15-07-2025	16 d early	2025-00275666
31-12-2023	31-07-2024	31-07-2024	on the day	2024-00333537
31-12-2022	31-07-2023	25-07-2023	6 d early	2023-00281836

Metric	This company	Sector median	Position in the sector
Solvency	91.7%	60.6%	better than 94% of 12464 sector peers
Net result	€74k	€31k	better than 79% of 12466 sector peers
Equity	€319k	€63k	better than 92% of 12472 sector peers
Gross operating margin	€118k	€52k	better than 81% of 12452 sector peers
Total assets	€348k	€124k	better than 82% of 12465 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€348k
Fixed assets	21/28	€16k
Tangible fixed assets	22/27	€16k
Current assets	29/58	€332k
Amounts receivable within one year	40/41	€25k
Cash & bank	54/58	€302k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€348k
Equity	10/15	€319k
Contributions / capital	10/11	€5k
Reserves	13	€314k
Amounts payable	17/49	€29k
Amounts payable within one year	42/48	€28k
Trade debts payable within one year	44	€113
Income statement
Gross operating margin	9900	€118k
Operating result	9901	€106k
Financial income	75	€4
Financial charges	65	€215
Result before taxes	9903	€105k
Income taxes	67/77	€32k
Net result for the period	9904	€74k
Result to be appropriated	9905	€74k

Summary

Legal nameFR	PHARMA AND CCS CONSULTING
Trade nameFR	PHARMA AND CCS CONSULTING